| payload |
{"created_at":"2026-04-17T14:05:37.124 {"created_at":"2026-04-17T14:05:37.124354+00:00","signal_type":"news_headline_delta","source":"news_rss","url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPQ203YlF5ZWJkd1Z4dEZ5ZEdQMmpTczdObVh1V3JUUWQxaWViV2pkeXFFZ0hqMy1CWWxQR2RSRHVFN2N4WnF2Y1BzU3gwT3dpRjNuWXVUek96dXdBWTNQRWxDdlQ2OGlmUDRkdWlzR29rYm1sNXluT3BhcEFMT0JMUVpoZksyUDdxcUpsMA?oc=5","value":{"fp":"74e86e339eabd6d9","published_at":"2026-04-17T09:04:01+00:00","source":"The New York Times","source_domain":"nytimes.com","source_url":"https://www.nytimes.com","summary":"New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs The New York Times First-of-its-kind Pitt study allows some liver transplant recipients to stop antirejection drugs Pittsburgh Post-Gazette Cell therapy primed liver transplant patients to avoid organ rejection, small study shows statnews.com First-in-human trial primes immune system to accept donor livers Medical Xpress First-Ever Human Trial Trains Immune System to Accept Donor Livers Bioengineer.org","title":"New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs - The New York Times","url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPQ203YlF5ZWJkd1Z4dEZ5ZEdQMmpTczdObVh1V3JUUWQxaWViV2pkeXFFZ0hqMy1CWWxQR2RSRHVFN2N4WnF2Y1BzU3gwT3dpRjNuWXVUek96dXdBWTNQRWxDdlQ2OGlmUDRkdWlzR29rYm1sNXluT3BhcEFMT0JMUVpoZksyUDdxcUpsMA?oc=5"}}... |